The Affordable Care Act (ACA) imposes a fee on health
insurance issuers and self-insured plan sponsors in order to fund comparative
effectiveness research. These fees are widely known as Patient-Centered
Outcomes Research Institute (PCORI) fees, and were originally scheduled to
expire for plan or policy years ending on or after Oct. 1, 2019. However, a
federal spending
bill enacted at the end of 2019 extended
the PCORI fees for an additional 10 years.
As a result, on June 8, 2020,
the Internal Revenue Service (IRS) issued Notice 2020-44, which
increases the PCORI fee amount for plan years ending on or after Oct. 1, 2019,
and before Oct. 1, 2020, to $2.54 multiplied
by the average number of lives covered under the plan. It also provides transition relief for calculating the
average number of lives covered under the plan or policy (which is what the
PCORI fee is based on).
Transition Relief
Specifically, issuers and plan sponsors may use any reasonable method for calculating
the average number of covered lives for this period, in addition to existing
methods, so long as it is applied
consistently for the duration of the plan year.
Form 720
No comments:
Post a Comment